The proposed role of ultrasound in the management of giant cell arteritis in routine clinical practice

被引:55
|
作者
Monti, Sara [1 ,2 ]
Floris, Alberto [3 ]
Ponte, Cristina B. [4 ]
Schmidt, Wolfgang A. [5 ,6 ]
Diamantopoulos, Andreas P. [7 ]
Pereira, Claudio [1 ]
Vaggers, Sophie [1 ]
Luqmani, Raashid A. [1 ]
机构
[1] Univ Oxford, Nuffield Orthopaed Ctr, Dept Rheumatol, NDORMS, Oxford, England
[2] Univ Pavia, IRCCS Policlin S Matteo Fdn, Dept Rheumatol, I-27100 Pavia, Italy
[3] Univ Clin & AOU Cagliari, Rheumatol Unit, Cagliari, Italy
[4] Univ Lisbon, Lisbon Acad Med Ctr, Fac Med, Dept Rheumatol,Hosp Santa Maria,CHLN, Lisbon, Portugal
[5] Univ Lisbon, Lisbon Acad Med Ctr, Fac Med, Rheumatol Res Unit,Inst Med Mol, Lisbon, Portugal
[6] Med Ctr Rheumatol Berlin Buch, Immanuel Krankenhaus Berlin, Berlin, Germany
[7] Martina Hansens Hosp, Dept Rheumatol, Baerum Oslo, Norway
基金
英国医学研究理事会;
关键词
giant cell arteritis; colour duplex sonography; diagnosis; follow-up; flare; routine clinical care; ULTRASONOGRAPHY FINDINGS; TEMPORAL ARTERITIS; COMPRESSION SIGN; DIAGNOSIS;
D O I
10.1093/rheumatology/kex341
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. To develop and explore a protocol for using colour duplex sonography (CDS) in the routine care of GCA. Methods. We tested CDS of temporal arteries and axillary arteries (AXs) on consecutive patients with suspected or established GCA, between July 2014 and September 2016. Results. We assessed 293 patients [age 72 (10), female/male 196/97], of whom 118 had clinically confirmed GCA. Seventy-three percent of patients had already received high-dose glucocorticoids (GCs) for 17 (33) days. Among new referrals with < 7 days of GC treatment (n = 55), the sensitivity of CDS was 63.3% (95% CI: 44%, 80%), specificity 100% (95% CI: 83%, 100%), positive predictive value 100% and negative predictive value 64.5% (95% CI: 53%, 74%). Sensitivity rose to 81.8% in patients with jaw claudication and high inflammatory markers. During the observation period, the rate of temporal artery biopsies decreased from 72 (42%) to 36 (25%) (P = 0.002). CDS was positive in 21% of 89 follow-up scans in asymptomatic individuals, compared with 37% in patients experiencing clinical flares. Over time, the number of halos reduced; only new or flaring patients showed a halo in four or more sites. The diameter of axillary halos reduced from referral [1.6 (0.4) mm] to follow-up [1.4 (0.2) mm, P = 0.01] or flares [1.4 (0.2) mm, P = 0.02]. Conclusion. CDS provides high positive predictive value for diagnosing GCA and allows for a significant reduction in temporal artery biopsies. We explored the role of CDS in detecting flares and demonstrated a relationship to the extent of the distribution of halos, but not to their size.
引用
收藏
页码:112 / 119
页数:8
相关论文
共 50 条
  • [41] Quantitative ultrasound to monitor the vascular response to tocilizumab in giant cell arteritis
    Seitz, Luca
    Christ, Lisa
    Loetscher, Fabian
    Scholz, Godehard
    Sarbu, Adela-Cristina
    Buetikofer, Lukas
    Kollert, Florian
    Schmidt, Wolfgang A.
    Reichenbach, Stephan
    Villiger, Peter M.
    RHEUMATOLOGY, 2021, 60 (11) : 5052 - 5059
  • [42] Doppler ultrasound and giant cell arteritis
    Suelves, Ana Marina
    Espana-Gregori, Enrique
    Tembl, Jose
    Rohrweck, Stephanie
    Millan, Jose Maria
    Diaz-Llopis, Manuel
    CLINICAL OPHTHALMOLOGY, 2010, 4 : 1383 - 1384
  • [43] Evolution of ultrasound in giant cell arteritis
    Kirby, Colm
    Flood, Rachael
    Mullan, Ronan
    Murphy, Grainne
    Kane, David
    FRONTIERS IN MEDICINE, 2022, 9
  • [44] Is Routine Imaging of the Aorta Warranted in Patients With Giant Cell Arteritis?
    Chen, John J.
    Warrington, Kenneth J.
    Garrity, James A.
    Prasad, Sashank
    JOURNAL OF NEURO-OPHTHALMOLOGY, 2017, 37 (03) : 314 - 319
  • [45] The use of ultrasound to assess giant cell arteritis: review of the current evidence and practical guide for the rheumatologist
    Monti, Sara
    Floris, Alberto
    Ponte, Cristina
    Schmidt, Wolfgang A.
    Diamantopoulos, Andreas P.
    Pereira, Claudio
    Piper, Jennifer
    Luqmani, Raashid
    RHEUMATOLOGY, 2018, 57 (02) : 227 - 235
  • [46] The role of color duplex sonography in the diagnosis of giant cell arteritis
    Romera-Villegas, A
    Vila-Coll, R
    Poca-Dias, V
    Cairols-Castellote, MA
    JOURNAL OF ULTRASOUND IN MEDICINE, 2004, 23 (11) : 1493 - 1498
  • [47] Diagnosis and management of giant cell arteritis: a review
    Kale, Nilufer
    Eggenberger, Eric
    CURRENT OPINION IN OPHTHALMOLOGY, 2010, 21 (06) : 417 - 422
  • [48] Development of outcome measures for giant cell arteritis for use in clinical trials and standard practice
    El Miedany, Yasser
    Elgaafary, Maha
    Toth, Mathias
    Azim, Atef Abdel
    Palmer, Deborah
    Dolbear, Gillian
    Abu-zaid, Mohamed Hassan
    Affam, Dora
    Hassan, Waleed
    Elnady, Bassant
    Tabra, Samar abdAlhamed
    Saber, Sally
    CLINICAL RHEUMATOLOGY, 2023, 42 (11) : 3049 - 3057
  • [49] An update on the clinical approach to giant cell arteritis
    Piccus, Rachel
    Hansen, Michael Stormly
    Hamann, Steffen
    Mollan, Susan P.
    CLINICAL MEDICINE, 2022, 22 (02) : 107 - 111
  • [50] The role of biologics in the treatment of giant cell arteritis
    Gonzalez-Gay, Miguel A.
    Pina, Trinitario
    Prieto-Pena, Diana
    Calderon-Goercke, Monica
    Blanco, Ricardo
    Castaneda, Santos
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2019, 19 (01) : 65 - 72